The team at GV manages some $10 billion that the tech giant has set aside for early-stage companies. Schenkein’s group ...

In summary, under the Trump plan, the U.S. health system continues to fail Americans — by not viewing obesity as a disease, ...

FDA decision-making may be reduced to a sequence of ‘make-a-deals’ with Trump, his FDA, or even political allies,” experts ...

In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

This week on "The Readout LOUD," STAT reporters have an in-depth chat with Mark Cuban about the direct-to-consumer trend and why he thinks TrumpRx is good.

The new report reveals that many of the authors and reviewers have been outspoken critics of gender-affirming care and belong ...

To secure Cassidy’s decisive confirmation vote, Kennedy committed to maintaining the Centers for Disease Control and ...

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

The changes are the latest move by the federal health department, led by Robert F. Kennedy Jr., to sow doubt about childhood ...

Function Health's $300 million fundraise, K Health's primary care play, new AI startup from Berkeley, and more.

Pfizer and Tris Pharma will pay $41.5 million to settle allegations they provided an ADHD medicine knowing about “flawed” manufacturing practices ...